JP2017008001A5 - - Google Patents

Download PDF

Info

Publication number
JP2017008001A5
JP2017008001A5 JP2015127861A JP2015127861A JP2017008001A5 JP 2017008001 A5 JP2017008001 A5 JP 2017008001A5 JP 2015127861 A JP2015127861 A JP 2015127861A JP 2015127861 A JP2015127861 A JP 2015127861A JP 2017008001 A5 JP2017008001 A5 JP 2017008001A5
Authority
JP
Japan
Prior art keywords
composition according
protective composition
retinal protective
vitamin
retinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015127861A
Other languages
Japanese (ja)
Other versions
JP2017008001A (en
JP6646368B2 (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2015127861A priority Critical patent/JP6646368B2/en
Priority claimed from JP2015127861A external-priority patent/JP6646368B2/en
Publication of JP2017008001A publication Critical patent/JP2017008001A/en
Publication of JP2017008001A5 publication Critical patent/JP2017008001A5/ja
Application granted granted Critical
Publication of JP6646368B2 publication Critical patent/JP6646368B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (6)

ルテインと、下記(a)〜(d)からなる群より選ばれる少なくとも1種の成分とを有効成分として含有することを特徴とする網膜保護組成物。
(a)ビタミンB1、ビタミンD3、ビオチン、ビタミンK、カルシウム、マンガン、亜鉛、鉄、モリブデン、及びクロムから選ばれる少なくとも1種のビタミン・ミネラル類
(b)アルギニン、フェニルアラニン、セリン、トレオニン、トリプトファン、及びチロシンから選ばれる少なくとも1種のアミノ酸
(c)没食子酸、及びクロロゲン酸から選ばれる少なくとも1種のポリフェノール
(d)葛、稲、及びココヤシから選ばれる少なくとも1種の植物素材
A retinal protective composition comprising lutein and at least one component selected from the group consisting of the following (a) to (d) as active ingredients.
(A) Vitamin B1, Vitamin D3, Biotin, Vitamin K, Calcium, Manganese, Zinc, Iron, Molybdenum, and Chromium (b) Arginine, Phenylalanine, Serine, Threonine, Tryptophan, And at least one amino acid selected from tyrosine (c) at least one polyphenol selected from gallic acid and chlorogenic acid (d) at least one plant material selected from kuzu, rice and coconut
網膜保護作用を有する眼機能維持剤であることを特徴とする請求項1記載の網膜保護組成物。   The retinal protective composition according to claim 1, which is an eye function maintaining agent having a retinal protective action. ルテインと(a)〜(d)からなる群より選ばれる少なくとも1種の成分とからなる有効成分を添加して得たことを特徴とする請求項1又は2記載の網膜保護組成物。   The retinal protective composition according to claim 1 or 2, which is obtained by adding an active ingredient comprising lutein and at least one component selected from the group consisting of (a) to (d). 経口用であることを特徴とする請求項1〜3のいずれか記載の網膜保護組成物。   The retinal protective composition according to any one of claims 1 to 3, which is for oral use. 錠剤、カプセル剤、粉末剤、顆粒剤、又は液剤であることを特徴とする請求項4記載の網膜保護組成物。   The retinal protective composition according to claim 4, which is a tablet, capsule, powder, granule, or liquid. 請求項1〜5のいずれか記載の網膜保護組成物を摂取させることを特徴とする眼機能維持方法(ただし、医療行為を除く)。   A method for maintaining an eye function, wherein the retinal protective composition according to any one of claims 1 to 5 is ingested (except for medical practice).
JP2015127861A 2015-06-25 2015-06-25 Retinal protective composition Active JP6646368B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2015127861A JP6646368B2 (en) 2015-06-25 2015-06-25 Retinal protective composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015127861A JP6646368B2 (en) 2015-06-25 2015-06-25 Retinal protective composition

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019129277A Division JP6736137B2 (en) 2019-07-11 2019-07-11 Retinal protection composition

Publications (3)

Publication Number Publication Date
JP2017008001A JP2017008001A (en) 2017-01-12
JP2017008001A5 true JP2017008001A5 (en) 2019-03-14
JP6646368B2 JP6646368B2 (en) 2020-02-14

Family

ID=57760779

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015127861A Active JP6646368B2 (en) 2015-06-25 2015-06-25 Retinal protective composition

Country Status (1)

Country Link
JP (1) JP6646368B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019019072A (en) * 2017-07-14 2019-02-07 寿スピリッツ株式会社 Method for producing retina protecting agent, and retina protecting agent
JP7231232B2 (en) * 2020-03-31 2023-03-01 株式会社東洋新薬 oral composition
CN111440767B (en) * 2020-04-24 2023-07-21 尚禾粒线体生物科技(深圳)有限公司 Mitochondrial protective agent and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2882894B1 (en) * 2005-03-11 2009-04-03 Larena Sa SUPPLETIVE FOOD COMPOSITION
US7829126B2 (en) * 2005-10-26 2010-11-09 Abbott Laboratories Infant formulas containing docosahexaenoic acid and lutein
RU2315612C1 (en) * 2006-08-29 2008-01-27 Открытое Акционерное Общество Завод Экологической Техники И Экопитания "Диод" Agent for treatment of eye disease
US20100159029A1 (en) * 2008-12-23 2010-06-24 Alcon Research, Ltd. Composition and nutritional supplements for improving ocular health and reducing ocular inflammatory response

Similar Documents

Publication Publication Date Title
PH12018500212A1 (en) 1,3,4-oxadiazole sulfonamide derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
WO2016064082A3 (en) Novel aminoalkyl benzothiazepine derivative and use thereof
BR112017027798A2 (en) 1,3,4-oxadiazole sulfamide derivative compounds as a histone deacetylase 6 inhibitor and the pharmaceutical composition comprising the same
PH12016501310A1 (en) Pharmaceutical compositions comprising azd9291
WO2013066839A3 (en) Compounds and methods
WO2013066835A3 (en) Compounds and methods
WO2017053868A8 (en) C4-modified oleanolic acid derivatives for inhibition of il-17 and other uses
MY193740A (en) "substituted 2,4 diamino-quinoline as new anticancer agents"
WO2016016380A8 (en) 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
WO2016046260A8 (en) 1-alkyl-6-oxo-1,6-dihydropyridin-3-yl compounds and use as sgrm modulators
HRP20220683T1 (en) Treatment for parkinson's disease
JP2017008001A5 (en)
JP2017014155A5 (en)
JP2016515550A5 (en)
EP4311575A3 (en) Methotrexate for proliferative vitreoretinopathy
JP2017012144A5 (en)
WO2016006974A3 (en) Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof
WO2016006975A3 (en) Novel imidazotriazinone or imidazopyrazinone derivatives, and use thereof
EP3248603A4 (en) Pharmaceutical composition for prevention, treatment or delay of alzheimer's disease or dementia containing g protein-coupled receptor 19 agent as active ingredient
WO2015001541A3 (en) Pharmaceutical film composition
JP2016210757A5 (en)
WO2016197042A8 (en) Modified or targeted release formulations of linaclotide
JP2016216373A5 (en)
JP2017014164A5 (en)
JP2017002009A5 (en)